Transplant rejection occurs when the body’s immune system recognizes a newly transplanted organ as foreign and launches an attack against it, potentially threatening the survival of the lifesaving transplant.

Understanding Transplant Rejection

When someone receives an organ transplant, whether it’s a kidney, liver, heart, lung, or pancreas, their body faces a unique challenge. The immune system, which normally protects us from harmful invaders like bacteria and viruses, can also see the transplanted organ as something that doesn’t belong. This recognition triggers a defensive response where the immune system tries to destroy what it perceives as a threat. This process is what doctors call transplant rejection.^[1]

Your immune system works by identifying specific proteins called antigens on the surface of cells. These antigens are like identification tags that tell your body whether something belongs to you or comes from outside. When a transplanted organ comes from another person, it carries different antigens than your own tissues. Even when doctors carefully match donors and recipients, the match is rarely perfect. Only identical twins have exactly the same tissue antigens, which is why transplants between identical twins are almost never rejected.^[1]

The reality is that some degree of rejection is very common after organ transplantation. Healthcare providers work hard to prevent and manage rejection through careful matching before surgery and lifelong medication afterward. While the word “rejection” sounds frightening, it doesn’t always mean the transplant will fail. Many rejection episodes can be treated successfully, especially when caught early.^[2]

How Common Is Transplant Rejection

Transplant rejection affects a significant number of people who receive new organs. For kidney transplants specifically, about 15% to 20% of recipients will experience some type of rejection. The severity of these rejection episodes varies considerably from person to person. Some people have mild rejection that responds quickly to treatment, while others face more serious challenges.^[2]

The risk of rejection is highest in the early months after transplant surgery. Most acute rejection episodes happen within the first six months, with the first several weeks being the most critical period. However, rejection can potentially occur at any time, even years after a transplant. While the risk decreases as time passes and the body adjusts to the new organ, it never disappears completely. This is why transplant recipients must take anti-rejection medications for the rest of their lives and maintain regular contact with their transplant team.^[2]

Interestingly, not all transplanted organs face the same rejection risk. Cornea transplants, for example, are rarely rejected because the cornea has no blood supply, which means the immune system has limited access to it. This makes corneal transplants much less complicated from an immunological standpoint than solid organ transplants.^[1]

Causes of Transplant Rejection

Transplant rejection happens because of a fundamental biological response built into every human body. The immune system has evolved over millions of years to protect us from disease by identifying and eliminating anything that appears foreign or potentially harmful. This same protective mechanism that keeps us healthy can work against transplant recipients.^[1]

When an organ from one person is placed into another person’s body, the recipient’s immune system detects that the antigens on the donor organ’s cells don’t match their own. This mismatch signals to the immune system that the organ is foreign. In response, the body mobilizes its defenses, sending immune cells and producing antibodies designed to attack and destroy the transplanted tissue. Without intervention, this immune response would almost certainly destroy the donor organ.^[1]

The likelihood of rejection depends on how closely matched the donor and recipient are. Healthcare providers perform extensive testing before transplantation to find the best possible match. This includes blood type matching and testing for compatibility of specific antigens called human leukocyte antigens (HLA). The more similar these antigens are between donor and recipient, the less aggressive the immune response is likely to be. However, even with the best matching, some degree of incompatibility usually remains.^[4]

Sometimes rejection is triggered or worsened by factors beyond the initial immune response. Not taking anti-rejection medications as prescribed is a major cause of rejection episodes. Even missing a few doses can allow the immune system to mount an attack on the transplanted organ. Infections can also complicate matters by activating the immune system, potentially increasing the risk of rejection.^[2]

Risk Factors for Rejection

Several factors can increase a person’s risk of experiencing transplant rejection. Understanding these risk factors helps healthcare teams provide better preventive care and helps patients know what to watch for.

One significant risk factor is having received a previous transplant. About 80% of people who have had an earlier transplant develop antibodies against other tissue types. This makes subsequent transplants more challenging because the immune system has already been exposed to foreign antigens and is primed to respond more aggressively. Similarly, people who have received blood transfusions or women who have been pregnant may have developed antibodies that increase rejection risk. Pregnancy exposes a woman’s immune system to antigens from the baby’s father, potentially creating antibodies that complicate future transplantation.^[22]

The quality of antigen matching between donor and recipient plays a crucial role. Poor matches or complete mismatches significantly increase rejection risk. Blood type compatibility is especially critical. If someone receives an organ from a donor with an incompatible blood type, hyperacute rejection can occur within minutes, requiring immediate removal of the transplanted organ.^[1]

Medication non-adherence represents one of the most controllable risk factors. People who don’t take their anti-rejection medications exactly as prescribed face much higher rejection rates. This can happen for many reasons, including forgetfulness, side effects, cost concerns, or simply not understanding how critical consistent medication use is for transplant survival.^[2]

Infections pose another risk because they activate the immune system. When the body is fighting an infection, immune activity increases throughout the body, which can inadvertently trigger or worsen rejection of the transplanted organ. Some infections may also require medications that interact with or reduce the effectiveness of anti-rejection drugs.^[16]

Types of Transplant Rejection

Medical professionals classify transplant rejection into three main types based on when it occurs and how it develops. Each type has different characteristics, causes, and treatment approaches.

Hyperacute rejection is the most severe and fastest form of rejection, but thankfully, it’s extremely rare today. This type occurs within minutes to hours after the transplant surgery is completed. Hyperacute rejection happens when the recipient has pre-formed antibodies that immediately attack the donor organ. These antibodies recognize the donor tissue as completely incompatible and trigger an overwhelming immune response that rapidly destroys the transplanted organ. When hyperacute rejection occurs, the organ must be removed immediately to save the recipient’s life. Modern tissue cross-matching techniques performed before surgery can almost always prevent this type of rejection by identifying incompatible donor-recipient pairs ahead of time.^[6]

Acute rejection is the most common type that transplant recipients face. This form of rejection typically occurs within the first 12 months after transplantation, most often appearing between one week and three months after surgery. Acute rejection develops when the recipient’s immune system gradually recognizes the transplanted organ as foreign and begins mounting an attack against it. The term “acute” refers to how relatively quickly this rejection develops compared to chronic rejection. All transplant recipients experience some amount of acute rejection, though the severity varies widely. The good news is that acute rejection is usually reversible when caught early and treated promptly with appropriate medications. About 15% or less of people who receive a deceased donor kidney transplant will have a noticeable episode of acute rejection.^[6]

Chronic rejection develops slowly over months or years following transplantation. Unlike acute rejection, which happens relatively quickly, chronic rejection is a gradual process where the body’s immune system continuously attacks the transplanted organ at a low level. Over time, this constant immune activity causes scarring and damage within the transplanted tissue. Chronic rejection is thought to be influenced by factors like blood pressure control, blood sugar management, and cholesterol levels. Because it progresses slowly and often without obvious symptoms, chronic rejection is frequently discovered through routine blood tests or biopsies rather than through symptoms noticed by the patient. Currently, there are no medications that can reverse chronic rejection once it’s established, though treatments can sometimes slow its progression.^[6]

Rejection can also be classified by the type of immune response involved. T-cell-mediated rejection occurs when specialized white blood cells called T lymphocytes attack the transplanted organ. Antibody-mediated rejection happens when the immune system produces antibodies that bind to the blood vessels in the transplanted organ, causing damage. Some patients experience both types simultaneously.^[2]

Symptoms of Transplant Rejection

The symptoms of transplant rejection vary depending on which organ has been transplanted and how severe the rejection is. Some rejection episodes cause noticeable symptoms, while others can only be detected through medical tests. This is why regular monitoring by healthcare providers is so important for all transplant recipients.

Many rejection symptoms are general and nonspecific, meaning they could indicate rejection or other health problems. These common symptoms include fever, often higher than 101 degrees Fahrenheit (38 degrees Celsius). People experiencing rejection may also develop flu-like symptoms such as chills, body aches, headaches, nausea, cough, and shortness of breath. A general feeling of discomfort, uneasiness, or illness is also common. Some people experience sudden weight gain, sometimes gaining 2 to 4 pounds or more within just 24 hours, usually due to fluid retention.^[2]

Specific symptoms often relate directly to the transplanted organ and its function. People who have received a kidney transplant may notice they are urinating less frequently or producing less urine than usual. They might experience new pain or tenderness in the area where the transplanted kidney was placed, typically in the lower abdomen. Swelling in the hands, feet, or other parts of the body can occur due to fluid buildup when the kidney isn’t functioning properly. Blood pressure may increase, and blood tests will show rising levels of creatinine, a waste product that healthy kidneys normally filter out.^[2]

For heart transplant recipients, rejection symptoms might include those similar to heart failure, such as increasing shortness of breath, reduced ability to exercise, or fatigue. Liver transplant recipients experiencing rejection might notice yellowing of the skin or eyes (jaundice) or develop easy bleeding or bruising. People with pancreas transplants may see their blood sugar levels become difficult to control. Lung transplant recipients might experience worsening shortness of breath or decreased exercise tolerance.^[1]

How Rejection Is Diagnosed

Healthcare providers use multiple methods to diagnose transplant rejection, ranging from routine monitoring to specialized tests. Regular surveillance is critical because some rejection episodes occur without obvious symptoms.

Blood tests are the most common screening tool for detecting rejection. Transplant recipients have blood drawn frequently, especially in the first few months after surgery, then at regular intervals for life. These tests measure how well the transplanted organ is functioning. For kidney transplants, doctors monitor creatinine levels in the blood. Rising creatinine suggests the kidney isn’t filtering waste properly, which could indicate rejection. Blood tests can also check for signs of liver damage, changes in blood sugar control for pancreas transplants, or other markers of organ function.^[1]

When blood tests or symptoms suggest possible rejection, doctors may order imaging studies. These can include ultrasounds, which use sound waves to create pictures of the transplanted organ and check blood flow through its vessels. CT scans or other imaging techniques might be used to look for structural changes or complications. However, imaging alone usually can’t definitively diagnose rejection.^[1]

The gold standard for diagnosing transplant rejection is a biopsy of the transplanted organ. During this procedure, a doctor removes a small sample of tissue from the organ, usually using a needle inserted through the skin under local anesthesia. A pathologist then examines this tissue sample under a microscope, looking for signs of immune system activity and tissue damage characteristic of rejection. The biopsy can determine whether rejection is occurring, what type it is, and how severe the damage is. Many transplant centers perform routine surveillance biopsies at scheduled intervals even when patients feel fine, as this can detect rejection before it causes noticeable symptoms or serious damage.^[1]

For heart transplant recipients, doctors may perform specialized tests like echocardiography to assess heart function. Kidney transplant patients might undergo ultrasound examinations or kidney arteriography. The specific tests used depend on which organ was transplanted and what abnormalities the healthcare team suspects.^[1]

Treatment of Transplant Rejection

The primary goal of treating transplant rejection is to suppress the immune system’s attack on the transplanted organ while still maintaining enough immune function to protect against infections. Treatment approaches vary depending on the type and severity of rejection.

For acute rejection, the most common first-line treatment is high-dose corticosteroids given through an intravenous (IV) line. These powerful anti-inflammatory medications can often reverse acute rejection if started quickly. Doctors typically administer these steroid pulses over several days while monitoring the patient closely, often in the hospital.^[7]

When steroid treatment doesn’t adequately control rejection, or when rejection is particularly severe, doctors may use stronger immunosuppressive agents. These include T-cell-depleting antibodies like Thymoglobulin, which work by eliminating the specific immune cells attacking the transplant. Other antibody therapies target different parts of the immune response, such as anti-CD20 antibodies that reduce B cells responsible for producing antibodies against the transplant.^[7]

For antibody-mediated rejection, treatment often involves a combination approach. Plasmapheresis, a procedure that filters antibodies out of the blood, is commonly used, though its effectiveness remains debated among medical professionals. This treatment is often combined with intravenous immunoglobulins (IVIG), which are preparations of antibodies that can help modulate the immune response. Other therapies may include complement inhibitors, which block a part of the immune system called the complement cascade, or proteasome inhibitors that target antibody-producing cells. The efficacy of these various treatments continues to be studied and refined.^[7]

Beyond treating active rejection, doctors typically adjust the patient’s maintenance immunosuppression regimen. This might mean increasing doses of existing medications, adding new anti-rejection drugs, or switching to different combinations of immunosuppressive agents. The goal is to find the right balance that prevents further rejection while minimizing side effects.^[2]

It’s crucial to understand that even with maximum treatment, some rejection episodes cannot be fully reversed. In these cases, the transplanted organ may suffer permanent damage that affects its function. Some organs may gradually lose function over time despite treatment. However, many patients whose organs don’t fully recover from rejection can still maintain adequate organ function for months or years, and some may eventually become candidates for another transplant.^[7]

Preventing Transplant Rejection

While transplant rejection cannot always be completely prevented, several strategies significantly reduce its likelihood and severity. Prevention begins before the transplant surgery and continues for the rest of the recipient’s life.

Before transplantation, healthcare teams work to find the best possible match between donor and recipient. This involves extensive testing of both the donor organ and the recipient’s blood and tissue. Blood type compatibility must be confirmed, and tissue typing compares the HLA antigens between donor and recipient. A cross-match test mixes the recipient’s blood with the donor’s cells to check for pre-existing antibodies that might cause immediate rejection. These careful matching procedures have dramatically reduced the incidence of hyperacute rejection.^[1]

The cornerstone of rejection prevention is lifelong use of immunosuppressive medications, also called anti-rejection drugs. Transplant recipients typically take a combination of two or three different immunosuppressive medications. These work through different mechanisms to suppress various parts of the immune response. Common maintenance medications include drugs like tacrolimus, cyclosporine, mycophenolate, azathioprine, and prednisone. The specific combination and dosing must be individualized for each patient based on their organ type, rejection risk, and how they tolerate the medications.^[12]

Taking medications exactly as prescribed is absolutely critical. Missing doses or taking medications inconsistently greatly increases rejection risk. Transplant recipients should never stop or change their medications without consulting their transplant team, even if they’re experiencing side effects. If cost is a barrier to obtaining medications, patients should discuss this with their healthcare team, as there may be assistance programs available.^[20]

Preventing infections is another important aspect of protecting the transplant. Because immunosuppressive medications weaken the immune system, transplant recipients are more vulnerable to infections. Good hand-washing hygiene, food safety practices, staying up to date with recommended vaccinations, and avoiding people who are sick can all help reduce infection risk. Some infections can trigger or worsen rejection, so prevention is crucial.^[16]

Maintaining overall health supports transplant longevity. For kidney transplant recipients, managing blood pressure, blood sugar (for those with diabetes), and cholesterol levels may help prevent chronic rejection. Regular exercise, a healthy diet low in salt and fat, staying hydrated, and managing stress all contribute to better outcomes. Avoiding tobacco and limiting alcohol consumption are also important.^[14]

Regular follow-up with the transplant team is essential. These appointments allow healthcare providers to monitor organ function through blood tests and physical exams, adjust medications as needed, and detect any problems early when they’re most treatable. Patients should attend all scheduled appointments and have all recommended laboratory tests performed on time.^[2]

How the Body Changes During Rejection

Understanding what happens inside the body during transplant rejection helps explain why the symptoms occur and why treatment is so important. The changes involve complex interactions between the immune system and the transplanted organ at multiple levels.

At the cellular level, rejection begins when the recipient’s immune cells encounter the donor organ. Specialized immune cells called T lymphocytes recognize the foreign antigens on the donor organ’s cells. These T cells become activated and multiply, creating an army of cells specifically programmed to attack the transplant. The activated T cells travel to the transplanted organ and begin infiltrating its tissues. Once there, they directly attack the organ’s cells and release inflammatory chemicals that cause tissue damage and recruit more immune cells to join the assault.^[4]

In antibody-mediated rejection, the immune system produces specialized proteins called antibodies that target the transplanted organ. These antibodies circulate through the bloodstream and bind to the inner lining of blood vessels within the transplant. This binding triggers a cascade of immune reactions that damage the blood vessel walls and can cause blood clots to form. As blood flow becomes impaired, the transplanted organ suffers from inadequate oxygen and nutrient delivery, leading to tissue injury and dysfunction.^[7]

The physical manifestations of these immune attacks vary by organ. In a rejecting kidney, immune cells infiltrate the kidney tissue, causing inflammation and swelling. The tiny filtering units called nephrons become damaged and stop working properly. This leads to a buildup of waste products like creatinine in the blood and can cause fluid retention, explaining symptoms like swelling and weight gain. The kidney may become tender and enlarged due to inflammation.^[2]

During chronic rejection, the ongoing immune response leads to progressive scarring, called fibrosis, within the transplanted organ. Blood vessels become thickened and narrowed, reducing blood flow. Normal functional tissue is gradually replaced with scar tissue that cannot perform the organ’s functions. This process happens slowly over months or years, which is why chronic rejection often develops silently without obvious symptoms until significant damage has occurred.^[6]

The biochemical changes during rejection affect multiple body systems. Inflammatory chemicals released during the immune response can cause fever and flu-like symptoms. Depending on the organ involved, rejection disrupts normal metabolic processes. A rejecting pancreas fails to produce adequate insulin, causing blood sugar to rise. A rejecting liver cannot properly process toxins or produce proteins needed for blood clotting, leading to jaundice and bleeding problems.^[1]

These pathophysiological processes explain why early detection and treatment are so critical. Once significant scarring and permanent tissue damage occur, even successful treatment of the immune response cannot restore lost function. This is why surveillance through regular testing and biopsies aims to catch rejection in its early stages, when intervention can still prevent lasting harm to the transplanted organ.